In high- and standard-risk patients CAS and TCAR look good, but some worry about skill sets, learning curves, and ...

A “bioadaptive” stent might circumvent the slow accumulation of target lesion failure that has been a consistent weakness of ...

Solaris Endovascular today announced its formation to develop solutions for dialysis access and treating peripheral artery ...

Stents are, of course, used in other scenarios to open large arteries. However, the new stent, with its unique pinched-in-the ...

The global Coronary Stents Market is projected to reach a substantial USD 51.2 billion by 2032, reflecting a steady growth ...

Stents are, of course, used in other scenarios to open large arteries. The new stent, with its unique pinched-in-the-middle ...

Abbott has delivered new, longer-term data from a clinical study of its dissolving stent for severe peripheral artery disease ...

Unlike tube-shaped stents used to open clogged arteries, the hourglass-shaped stent narrows in the middle. The different ...

As the technology continues to advance, magnetoelastic sensors have the potential to be used in other places in the body ...

Although the device is used in the West, AIIMS is testing a version that’s more suited to Indians and is cost-effective ...

For patients with severely calcified coronary lesions, routine treatment with orbital atherectomy prior to drug-eluting stent ...

Subsequently, the Novoste Corporation, located in Norcross, Georgia—which started conducting BetaCath clinical trials—began ...